ATL 1102 (sodium)
ATL 1102 (Avicursen) sodium is a novel second-generation antisense oligonucleotide to CD49d mRNA
Product Specifications
Product Name Alternative
ISIS-107248 (sodium) ; Avicursen (sodium)
UNSPSC
12352208
Target
Integrin
Type
Oligonucleotides
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/atl-1102-sodium.html
Solubility
10 mM in H2O
Smiles
[ATL1102(sodium)]
Molecular Formula
C233H307N60Na20O129P19S19
Molecular Weight
7230.14 (free acid)
References & Citations
[1]Duchartre Y, Bachl S, Kim HN, et al. Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies. PLoS One. 2017;12 (11) :e0187684. |[2]Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G; ATL1102 Study Group. CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS [published correction appears in Neurology. 2015 Jan 6;84 (1) :105]. Neurology. 2014;83 (20) :1780-1788.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
